Objective: Glioblastoma multiforme (GBM) is both the most common and lethal primary malignant brain tumor
This means that approximately 11,170 males and 9,330 females in the United States were diagnosed with a primary malignant brain tumor
in 2007 (Jemal et al.
The five-year survival following diagnosis of a primary malignant brain tumor
is approximately 32 percent.
Polifeprosan (Gliadel) was approved several years ago as a localized treatment for recurrent primary malignant brain tumor
Glioblastoma multiforme, a primary malignant brain tumor
, is a devastating diagnosis with little hope for cure.
The primary malignant brain tumor
grows within the brain matter itself, and is graded according to its degree of malignancy.
Malignant gliomas are the most commonly seen brain tumors among adults, accounting for 70% of primary malignant brain tumors
and 40% of all primary brain tumors.
Trends in reported incidence of primary malignant brain tumors
in children in the United States.
More than 18,000 primary malignant brain tumors
are diagnosed each year in the United States; about 9,000 of those are malignant gliomas, according to the National Cancer Institute.
is treating primary malignant brain tumors
with surgery followed by insertion of stimulated immune cells.